Chris is currently Senior Manager, Health Economics Outcomes Research and Pricing at Celgene, and previously spent over 5 years in health economics consulting at Oxford Outcomes/ICON. Chris has conducted and led the conceptual development and technical programming of health care decision models (cost-effectiveness and budget impact), network meta-analyses, and individual patient data analyses. Disease areas include Hodgkin’s and non-Hodgkin’s lymphoma, peripheral T-cell lymphomas, metastatic breast cancer, chronic myeloid leukaemia, gastric cancer, inflammatory bowel disease, Alzheimer’s disease, and human immunodeficiency virus (HIV). Chris has authored submission documentation to support reimbursement submissions to HTA bodies including NICE, SMC, and NCPE. Chris’s methodological interests include extrapolation modelling of clinical trial data including cure modelling and multi-state Markov modelling.